Cargando…
Retraction: Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756093/ https://www.ncbi.nlm.nih.gov/pubmed/35036357 http://dx.doi.org/10.3389/fonc.2021.839904 |
Ejemplares similares
-
Exosomal MicroRNA-221-3p Confers Adriamycin Resistance in Breast Cancer Cells by Targeting PIK3R1
por: Pan, Xiaoping, et al.
Publicado: (2020) -
MicroRNA‐221 promotes breast cancer resistance to adriamycin via modulation of PTEN/Akt/mTOR signaling
por: Yin, Yingchun, et al.
Publicado: (2020) -
METTL3 promotes adriamycin resistance in MCF-7 breast cancer cells by accelerating pri-microRNA-221-3p maturation in a m6A-dependent manner
por: Pan, Xiaoping, et al.
Publicado: (2021) -
Retraction: MicroRNA-367 directly targets PIK3R3 to inhibit proliferation and invasion of oral carcinoma cells
Publicado: (2022) -
[Retracted] MicroRNA‑212 inhibits colorectal cancer cell viability and invasion by directly targeting PIK3R3
por: Zhang, Jian, et al.
Publicado: (2023)